Gender-Specific Cytokine Pathways, Targets, and Biomarkers for the Switch from Health to Adenoma and Colorectal Cancer

Autor: Patrizia Pellegrini, Ida Contasta, Tiziana Del Beato, Fabiana Ciccone, Anna Maria Berghella

Publikováno v: Clinical and Developmental Immunology, Vol 2011 (2011)

Studies focusing on gender have shown that differences exist in how the immune system responds to disease and therapy. Understanding how gender influences immunological mechanisms in health and disease and identifying gender-specific biomarkers could

Externí odkaz: https://doaj.org/article/e2fa33ad289a46f7ad59a019e6a293d2

The Definition of a Panel of Clinical Biomarkers of Homeostasis: A New Promising Tool for Prevention and Treatment of Chronic-Degenerative Diseases

Autor: Patrizia Pellegrini, Ida Contasta, Anna Maria Berghella

Publikováno v: Journal of Molecular Biomarkers and Diagnosis 7 (2015). doi:10.4172/2155-9929.1000e123
info:cnr-pdr/source/autori:Anna Maria Berghella, Ida Contasta, and Patrizia Pellegrini/titolo:The definition of a panel of clinical biomarkers of homeostasis: a new promising tool for prevention and treatment of chronic-degenerative/doi:10.4172%2F2155-9929.1000e123/rivista:Journal of Molecular Biomarkers and Diagnosis/anno:2015/pagina_da:/pagina_a:/intervallo_pagine:/volume:7

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c888306055452eb2423ef1f71625e17
https://doi.org/10.4172/2155-9929.1000e123

The potential role of thioredoxin 1 and CD30 systems as multiple pathway targets and biomarkers in tumor therapy

Autor: Fabiana Ciccone, Patrizia Pellegrini, Tiziana Del Beato, Ida Contasta, Anna Maria Berghella

Publikováno v: Cancer Immunology, Immunotherapy

Our progress in understanding pathological disease mechanisms has led to the identification of biomarkers that have had a considerable impact on clinical practice. It is hoped that the move from generalized to stratified approaches, with the grouping

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bfb3f45bc9a9e307ddf3bdb512692c7
http://europepmc.org/articles/PMC3176405

Soluble CD30: A Biomarker for Evaluating the Clinical Risk versus Benefit of IFNβ1A Treatment in Multiple Sclerosis Patients

Autor: A-M. Berghella, P. Pellegrini, T. Del Beato, Rocco Totaro, Antonio Carolei, Ida Contasta, Domenico Adorno

Publikováno v: Europe PubMed Central
International journal of immunopathology and pharmacology 23 (2010): 213–226.
info:cnr-pdr/source/autori:CONTASTA I; TOTARO R1; BERGHELLA AM; PELLEGRINI P; DEL BEATO T; CAROLEI A1; ADORNO D/titolo:Soluble CD30: a biomarker for evaluating the clinical risk versus benefit of IFNbeta1A treatment in multiple sclerosis patients./doi:/rivista:International journal of immunopathology and pharmacology/anno:2010/pagina_da:213/pagina_a:226/intervallo_pagine:213–226/volume:23
Scopus-Elsevier

Aberrant redox regulation occurs in immune and neurological pathologies, hence targeting the pathways involved in the regulation of the redox system could provide further insights into these diseases and open up new avenues for therapy. Soluble (s) C

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1e6e0a81f255c75b0f66387d70bde1c
https://doi.org/10.1177/039463201002300119

Novel Prognostic Biomarkers for Personalized Cancer Treatment

Autor: Antonio Mongelli, Giampaolo Caterino, Maurizio Vizioli, Osvaldo Ciccarelli, Ida Contasta, P. Pellegrini, Enzo Secinaro, Marino Silvino, Tiziana Del Beato, Roberto Lattanzio, Luca Navarra, Luigi Liborio Liberatore, Irma Campitelli, Giancarlo Di Gregorio, Anna Maria Berghella, Nunzia Antonucci, Vincenzo Vittorini

Publikováno v: Cancer Immunology ISBN: 9783662449455
Cancer Immunology: Bench to Bedside Immunotherapy of Cancers, edited by Nima Rezaei, pp. 35–54. Berlin Heidelberg: Springer, 2015
info:cnr-pdr/source/autori:CONTASTA IDA 2, BERGHELLA ANNA MARIA 2, LATTANZIO ROBERTO 3, CICCARELLI OSVALDO 3, DI GREGORIO GIANCARLO 4, VIZIOLI MAURIZIO 5, SILVINO MARINO 6, LIBERATORE LUIGI LIBORIO 3, NAVARRA LUCA 3, CATERINO GIAMPAOL 3, MONGELLI ANTONIO 3, VITTORINI VINCENZO 3, CAMPITELLI IRMA 4, NUNZIA ANTONUCCI 3, DEL BEATO TIZIANA 2, SECINARO ENZO 7 AND PELLEGRINI PATRIZIA 2/titolo:Novel Prognostic Biomarkers for Personalized Cancer Treatment/titolo_volume:Cancer Immunology: Bench to Bedside Immunotherapy of Cancers/curatori_volume:Nima Rezaei/editore: /anno:2015

Neoplastic pathologies are one of the most frequent cause of death in the world and, in spite of the treatment's improvement, the related mortality of tumour is high. One of the principal cause of this situation is the lack of clinical prognostic bio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9788b660b8efef7249b00af1b61ea8e9
https://doi.org/10.1007/978-3-662-44946-2_3